Engineered nanomaterials for their applications in theragnostics
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Jangsun | - |
dc.contributor.author | Lee, Dohyun | - |
dc.contributor.author | Seo, Youngmin | - |
dc.contributor.author | Son, Jaewoo | - |
dc.contributor.author | Jo, Yeonho | - |
dc.contributor.author | Lee, Kyungwoo | - |
dc.contributor.author | Park, Chanhwi | - |
dc.contributor.author | Choi, Jonghoon | - |
dc.date.available | 2019-01-22T12:34:22Z | - |
dc.date.issued | 2018-10 | - |
dc.identifier.issn | 1226-086X | - |
dc.identifier.issn | 1876-794X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/648 | - |
dc.description.abstract | Owing to their abundant unique properties and ready compatibility with healthcare and therapeutic technology, nanoparticles are becoming one of the most desirable materials in the biomedical industry. Particularly, novel nanoparticles possess distinctive photoluminescence, biocompatibility, antibacterial effect, surface plasmon resonance, and immunogenicity. In this review, we describe the general synthesis, physical properties, cellular activity, and biological applications of popular nanoparticles/ nanomaterials (i.e., silicon, gold, iron oxide, and carbon nanotubes), while focusing on the immunology encompassing these nanoparticles and their potential applications in the fields of nanotherapy. We further highlight major challenges and promises in this area and review the uses of nanoparticles in current technologies, such as nanoparticle-mediated cellular immunology and cytotoxicity in therapeutic applications. (C) 2018 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved. | - |
dc.format.extent | 9 | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.title | Engineered nanomaterials for their applications in theragnostics | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.jiec.2018.05.022 | - |
dc.identifier.bibliographicCitation | JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, v.66, pp 20 - 28 | - |
dc.identifier.kciid | ART002396903 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000446144400002 | - |
dc.identifier.scopusid | 2-s2.0-85048541215 | - |
dc.citation.endPage | 28 | - |
dc.citation.startPage | 20 | - |
dc.citation.title | JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY | - |
dc.citation.volume | 66 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Silicon nanoparticles (SiNPs) | - |
dc.subject.keywordAuthor | Gold nanoparticles (GNPs) | - |
dc.subject.keywordAuthor | Iron oxide nanoparticles (IONPs) | - |
dc.subject.keywordAuthor | Carbon nanotube (CNT) | - |
dc.subject.keywordAuthor | Immunotherapy | - |
dc.subject.keywordPlus | IRON-OXIDE NANOPARTICLES | - |
dc.subject.keywordPlus | POROUS SILICON MICROPARTICLES | - |
dc.subject.keywordPlus | CHEMICAL-VAPOR-DEPOSITION | - |
dc.subject.keywordPlus | VISIBLE-LIGHT EMISSION | - |
dc.subject.keywordPlus | GOLD NANOPARTICLES | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | CARBON NANOTUBES | - |
dc.subject.keywordPlus | IMMUNE-SYSTEM | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | OPTICAL-PROPERTIES | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Engineering, Chemical | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.